share_log

Chardan Capital Maintains Buy on Omega Therapeutics, Lowers Price Target to $7

Chardan Capital Maintains Buy on Omega Therapeutics, Lowers Price Target to $7

Chardan Capital維持對歐米茄療法的買入,將目標股價下調至7美元
Moomoo 24/7 ·  04/01 08:24

Chardan Capital analyst Keay Nakae maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and lowers the price target from $12 to $7.

查爾丹資本分析師凱·納卡埃維持歐米茄療法(納斯達克股票代碼:OMGA)的買入並將目標股價從12美元下調至7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論